Author:
Murav’eva A. I.,Vorontsov E. A.,Gukasova N. V.,Zavarzina V. V.,Kuznetsov S. L.,Tubasheva I. A.,Semochkina Yu. P.,Moskaleva E. Yu.,Posypanova G. A.,Severin S. E.
Subject
General Engineering,Condensed Matter Physics,General Materials Science
Reference24 articles.
1. H. K. Makadia and S. J. Siegel, “Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled,” Drug Deliv. Carrier Polym. 3, 1377–1397 (2011).
2. K. R. Hande, “Etoposide: four decades of development of a topoisomerase II inhibitor,” Eur. J. Cancer 34, 1514–1521 (1998).
3. S. N. Wolff, M. F. Fer, C. M. McKay, K. R. Hande, J. D. Hainsworth, and F. A. Greco, “High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study,” J. Clin. Oncol. 1, 701–705 (1983).
4. J. Ciccolini, S. Monjanel-Mouterde, S. S. Bun, C. Blanc, F. Duffaud, R. Favre, and A. Durand, “Population pharmacokinetics of etoposide: application to therapeutic drug monitoring,” Ther. Drug. Monit. 24, 709–714 (2002).
5. K. Rudolf, M. Cervinka, and E. Rudolf, “Cytotoxicity and mitochondrial apoptosis induced by etoposide in melanoma cells,” Cancer Invest. 27, 704–717 (2009).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献